http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-102013004752-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb74510f0987793b6784fc84fb9a9a96
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-582
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-58
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B57-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-58
filingDate 2013-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c29ea156cfb9a0340212bb3fdcd97424
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61f4d6001bb9010d85f25aa2ecaa859e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5db4af3516726ce81eda146184d4648
publicationDate 2015-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-102013004752-A2
titleOfInvention Process for medetomidine transformation and unwanted enantiomer recovery
abstract Process for transformation of medetomidine and recovery of unwanted enantiomer. The present invention relates to a process for obtaining medetomidine enantiomers, a potent and selective β 2 receptor agonist. Such a process comprises a transformation stage and a racemization reaction, allowing recovery of unwanted enantiomer which can be recycled as a starting material.
priorityDate 2012-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407698410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407698412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447315
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311068
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68601
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581463
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453416344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92824
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415758420

Total number of triples: 36.